Literature DB >> 22084083

Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.

Corrie A Painter1, Maria P Negroni, Katherine A Kellersberger, Zarixia Zavala-Ruiz, James E Evans, Lawrence J Stern.   

Abstract

HLA-DM is required for efficient peptide exchange on class II MHC molecules, but its mechanism of action is controversial. We trapped an intermediate state of class II MHC HLA-DR1 by substitution of αF54, resulting in a protein with increased HLA-DM binding affinity, weakened MHC-peptide hydrogen bonding as measured by hydrogen-deuterium exchange mass spectrometry, and increased susceptibility to DM-mediated peptide exchange. Structural analysis revealed a set of concerted conformational alterations at the N-terminal end of the peptide-binding site. These results suggest that interaction with HLA-DM is driven by a conformational change of the MHC II protein in the region of the α-subunit 3(10) helix and adjacent extended strand region, and provide a model for the mechanism of DM-mediated peptide exchange.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22084083      PMCID: PMC3228433          DOI: 10.1073/pnas.1108074108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond.

Authors:  Andrea Ferrante; Jack Gorski
Journal:  J Immunol       Date:  2009-12-28       Impact factor: 5.422

2.  Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.

Authors:  Rakina Yaneva; Sebastian Springer; Martin Zacharias
Journal:  Biopolymers       Date:  2009-01       Impact factor: 2.505

3.  Mediation by HLA-DM of dissociation of peptides from HLA-DR.

Authors:  V S Sloan; P Cameron; G Porter; M Gammon; M Amaya; E Mellins; D M Zaller
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

4.  Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM.

Authors:  R Busch; Z Reich; D M Zaller; V Sloan; E D Mellins
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

5.  HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.

Authors:  C L Chou; S Sadegh-Nasseri
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

6.  Editing of the HLA-DR-peptide repertoire by HLA-DM.

Authors:  H Kropshofer; A B Vogt; G Moldenhauer; J Hammer; J S Blum; G J Hämmerling
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

Review 7.  Hydrogen/deuterium exchange-mass spectrometry: a powerful tool for probing protein structure, dynamics and interactions.

Authors:  Yuko Tsutsui; Patrick L Wintrode
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

8.  HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide.

Authors:  Anne-Kathrin Anders; Melissa J Call; Monika-Sarah E D Schulze; Kevin D Fowler; David A Schubert; Nilufer P Seth; Eric J Sundberg; Kai W Wucherpfennig
Journal:  Nat Immunol       Date:  2010-12-05       Impact factor: 25.606

9.  HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules.

Authors:  L K Denzin; C Hammond; P Cresswell
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  44 in total

1.  HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.

Authors:  Roberto Meza-Romero; Gil Benedek; Xiaolin Yu; Jeffery L Mooney; Rony Dahan; Nerri Duvshani; Richard Bucala; Halina Offner; Yoram Reiter; Gregory G Burrows; Arthur A Vandenbark
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

2.  Peptide modulation of class I major histocompatibility complex protein molecular flexibility and the implications for immune recognition.

Authors:  William F Hawse; Brian E Gloor; Cory M Ayres; Kevin Kho; Elizabeth Nuter; Brian M Baker
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

3.  Single-molecule motions of MHC class II rely on bound peptides.

Authors:  Haruo Kozono; Yufuku Matsushita; Naoki Ogawa; Yuko Kozono; Toshihiro Miyabe; Hiroshi Sekiguchi; Kouhei Ichiyanagi; Noriaki Okimoto; Makoto Taiji; Osami Kanagawa; Yuji C Sasaki
Journal:  Biophys J       Date:  2015-01-20       Impact factor: 4.033

Review 4.  HLA-DM: arbiter conformationis.

Authors:  Andrea Ferrante
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

5.  Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.

Authors:  Liusong Yin; Peter Trenh; Abigail Guce; Marek Wieczorek; Sascha Lange; Jana Sticht; Wei Jiang; Marissa Bylsma; Elizabeth D Mellins; Christian Freund; Lawrence J Stern
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

6.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

Review 7.  Selection of immunodominant epitopes during antigen processing is hierarchical.

Authors:  Scheherazade Sadegh-Nasseri; AeRyon Kim
Journal:  Mol Immunol       Date:  2018-08-24       Impact factor: 4.407

Review 8.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

9.  HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.

Authors:  Liusong Yin; J Mauricio Calvo-Calle; Omar Dominguez-Amorocho; Lawrence J Stern
Journal:  J Immunol       Date:  2012-09-10       Impact factor: 5.422

Review 10.  Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.